Atlas Trials

Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

Clinical trial NCT00606632 · COMPLETED

Trial details

NCT number
NCT00606632
Sponsor
Heidelberg Pharma AG
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Renal Cell CarcinomaKidney Cancer
Start date
2008-03-01
Primary completion
2009-11-01
Enrollment
226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.